Advertisement

Entzündliche Herzerkrankungen und Kardiomyopathien

  • Gerhard Riecker

Zusammenfassung

Nach klinisch-praktischen Gesichtspunkten haben die einzelnen Erkrankungen des Herzens eine unterschiedliche Wertigkeit hinsichtlich Morbidität und der Möglichkeiten des diagnostischen und therapeutischen Zugangs. Außerdem stehen je nach dem klinischen Bild einmal mehr diagnostische Überlegungen mit Fragen nach der Ätiologie und ein andermal mehr therapeutische Erwägungen im Vordergrund. Deshalb ergeben sich unterschiedliche Einteilungen der Erkrankungen des Herzens.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    WHO/ISFC Task Force (1980) Report on definition and classification of cardiomyopathies. Br Heart J 44: 672CrossRefGoogle Scholar
  2. 2.
    Kaplan MH (1965) Autoantibodies to heart and rheumatic fever: The induction of autoimmunity to heart by streptococcal antigen cross-reactive with heart. Ann NY Acad Sci 124: 903–915Google Scholar
  3. 3.
    Hess EV, Fink CW, Taranta A, Ziff M (1964) Heart muscle antibodies in rheumatic fever and other diseases. J Clin Invest 43: 886–893PubMedCrossRefGoogle Scholar
  4. 4.
    Bolte HD (1979) Immunerkrankungen des Herzens. Internist (Berlin) 20: 479Google Scholar
  5. 5.
    Durack DT, Petersdorf RG (1977) Changes in the epidemiology of endocarditis. In: Kaplan EL, Taranta AV (eds) Infective endocarditis — An American Heart Association Symposium, AHA Monograph No. 52, Dallas 1977, pp 3-8Google Scholar
  6. 6.
    Reler LB (1981) Laboratory procedures in the management of infective endocarditis. In: Bisno AL (ed): Treatment of infective endocarditis. Grune & Stratton, New York London Toronto, pp 235–267Google Scholar
  7. 7.
    Lode H, Harnoss CM, Wagner J, Biamino G, Schröder R (1982) Infektive Endokarditis: Klinik, Therapie und Verlauf bei 103 Erkrankungen. Dtsch Med Wochenschr 107: 967–974PubMedCrossRefGoogle Scholar
  8. 8.
    Zine-Eddine N (1977) Bakterielle Endocarditis. Dissertation, Frankfurt am MainGoogle Scholar
  9. 9.
    Cohen PS, Maguire JH, Weinstein L (1980) Infective endocarditis by gramnegative bacteria: A review of the literature, 1945–1977. Progr Cardiovasc Dis 22: 205–242CrossRefGoogle Scholar
  10. 10.
    Watanakunakorn C (1981) Antimicrobial therapy of endocarditis due to less common bacteria. In: Bisno AL (ed): Treatment of infective endocarditis. Grune & Stratton, New York London Toronto, pp 123–133Google Scholar
  11. 11.
    McLeod R, Remington JS (1978) Fungal endocarditis. In: Rahimtoola SH (ed): Infective Endocarditis. New York San Francisco London, pp 195-220Google Scholar
  12. 12.
    Anschütz F (1968) Endokarditis. Thieme, StuttgartGoogle Scholar
  13. 13.
    Stewart JA, Silimperi D, Harris PJ, Wise NK, Fraker TD, Kisslo TA (1980) Echokardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation 63: 374–380CrossRefGoogle Scholar
  14. 14.
    Lüthi R (1984) Therapie der Endokarditis, hervorgerufen durch Streptokokken, incl. Enterokokken, Staphylokokken. In: Verhandlungen der Deutschen Gesellschaft für Innere Medizin 90, S 126 ff.Google Scholar
  15. 15.
    Kim HS (1977) Nonbacterial, thrombotic endocarditis and disseminated intravascular coagulation: Autopsy study of 36 patients. Arch Pathol Lab Med 101: 65PubMedGoogle Scholar
  16. 16.
    Gnann JW, Dismukes WE (1983) Prosthetic valve endocarditis: an overview. Herz 8: 320–331PubMedGoogle Scholar
  17. 17.
    Burch GE, Giles TD (1972) The role of viruses in the production of heart disease. Am J Med 29: 231–240Google Scholar
  18. 18.
    Schultheiß H-P, Kühl U (1987) Charakterisierung verschiedener Autoantikörper gegen myokardiale Matrixproteine bei Myokarditis und dilativer Kardiomyopathie. Klin WochenschrGoogle Scholar
  19. 19.
    Schultheiss H-P, Bolte H-D (1985) The immunochemical characterization of the adenin nucleotide translocator as an organspecific autoantigen in dilated cardiomyopathy. J Mol Cell Cardiol 17: 603–617PubMedCrossRefGoogle Scholar
  20. 20.
    Maisch B, Deeg P, Liebau G, Kochsiek K (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 52: 1072–1078PubMedCrossRefGoogle Scholar
  21. 21.
    Schultheiss, H-P (1988) Virusmyokarditis — neue Aspekte zum Pathomechanismus, zur Diagnose und zur Therapie Wiener klin Wschr 100, H. 24: 779Google Scholar
  22. 22.
    Schultheiss, H-P (1989) The Significance of Autoantibodies against the ADP/ATP-carrier for the pathogenesis of myocarditis and dilated cardiomyopathy Springer Semin Immunopathol. 11: 15–30PubMedCrossRefGoogle Scholar
  23. 23.
    Zabriskie JB, Hsu KC, Seegal BC (1970) Heart-reactive antibody associated with rheumatic fever: Characterization and diagnostic significance. Clin Exp Immunol 7: 147–159PubMedGoogle Scholar
  24. 24.
    Krisher K, Myosin G (1985) A link between streptococci and heart. Science 227: 413–415PubMedCrossRefGoogle Scholar
  25. 25.
    McCabe J, Ebert P, Engle MA, Zabriskie JB (1973) Circulating heart-reactive antibodies in the postpericardiotomie syndrome. J Surg Res 14: 158–164PubMedCrossRefGoogle Scholar
  26. 26.
    Specter S, Cerdan A, Cerdan C, Chang K, Friedman H (1984) Cell-mediated immune responsiveness to cardiac extracts by peripheral blood leukocytes from patients after myocardial infarction or open-heart surgery. Clin Immunol Immunopathol 30: 19–28PubMedCrossRefGoogle Scholar
  27. 27.
    Dressler W (1959) The post-myocardial-infarction syndrome. AMA Arch Intern Med 103: 28–42PubMedCrossRefGoogle Scholar
  28. 28.
    Kandolf R, Hofschneider PH (1985) Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci USA 82: 4818–4822PubMedCrossRefGoogle Scholar
  29. 29.
    Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: An approach to the diagnosis of viral heart disease. Proc Natl Acad Sci USA 84: 6272–6276PubMedCrossRefGoogle Scholar
  30. 30.
    Kandolf R (1988) The impact of recombinant DNA technology on the study of enterovirus heart disease. In: Bendinelli M, Friedman H (eds) Coxsackieviruses — A General Update. Plenum Press, New York pp 293–318CrossRefGoogle Scholar
  31. 31.
    Kandolf R, Hofschneider PH (1989) Viral heart disease. Springer Semin Immunopathol 11: 1–13PubMedCrossRefGoogle Scholar
  32. 32.
    Kandolf R, Canu A, Hofschneider PH (1985) Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol 17: 167–181PubMedCrossRefGoogle Scholar
  33. 33.
    Kandolf R, Kirschner P, Ameis D, Canu A, Hofschneider PH (1987) Cultured human heart cells: a model system for the study of the antiviral activity of interferons. Eur Heart J [Suppl] 8: 453–456CrossRefGoogle Scholar
  34. 34.
    Bolte HD, Schultheiss P (1978) Immunological results in myocardial diseases. Postgrad Med J 54: 500PubMedCrossRefGoogle Scholar
  35. 35.
    Kawai C (1971) Idiopathic cardiomyopathy. A study on the infections-immune theory as a cause of the disease. Jpn Circ J 35: 765–770PubMedCrossRefGoogle Scholar
  36. 36.
    Holsinger DR, Osmundsoon PJ, Edwards JE (1962) The heart in periarteriitis nodosa. Circulation 25: 610PubMedCrossRefGoogle Scholar
  37. 37.
    Read SE, Engle MA, Zabriskie JD (1975) Humoral and cellular studies in diseases with heart reactive antibodies. In: Riecker G, Weber A, Goodwin J (eds) Myocardial failure. Springer, Berlin Heidelberg New York, p 201Google Scholar
  38. 38.
    Löffler W (1936) Endocarditis parietalis fibroplastica mit Bluteosinophilie. Ein eigenartiges Krankheitsbild. Schweiz Med Wochenschr 66: 817–820Google Scholar
  39. 39.
    Buja LM, Khoi NB, Roberts WC (1970) Clinically significant cardiac amyloidosis. Am J Cardiol 26: 394PubMedCrossRefGoogle Scholar
  40. 40.
    Erdmann E, Bolte HD, Strauer BE (1980) Myokardiale Beteiligung bei M. Fabry. Dtsch Med Wochenschr 105: 1618PubMedCrossRefGoogle Scholar
  41. 41.
    Bristow MR, Thompson PD, Martin RP, Mason JW, Billingham ME, Harrison DC (1978) Early anthracycline cardiotoxicity. Am J Med 65: 823PubMedCrossRefGoogle Scholar
  42. 42.
    Bristow MR, Mason JW, Billingham ME, Daniels JR (1978) Doxorubicin cardiomyopathy: Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med 88: 168PubMedCrossRefGoogle Scholar
  43. 43.
    Höfling B, Bolte HD (1978) The effect of adriamycin on the isometric concentration of guinea pig-papillary muscle. Naunyn Schmiedebergs Arch Pharmacol 302: 116Google Scholar
  44. 44.
    Höfling B, Bolte HD, Zähringer J (1980) Dobutamin-Dosis-Wirkungskurve am intakten und vorgeschädigten Myokard der Ratte. In: Bleifeld W, Gattiger R, Schaper W, Brade W (Hrsg) Dobutamin-Symposium. Urban & Schwarzenberg, München Wien Baltimore, S 43–46Google Scholar
  45. 45.
    Zähringer J. Höfling B (1980) Adriamycin-cardiomyopathy: Changes in myocardial polyribosoms and mRNA levels. In: Bolte HD (ed) Myocardial biopsy — diagnostic significance. Springer, Berlin Heidelberg New York, pp 119–130CrossRefGoogle Scholar
  46. 46.
    Farrar MW (1987) Response of left ventricular function to drug intervention. In: Gerson MC (ed) Cardiac nuclear medicine. McGraw Hill, New York, pp 193–233Google Scholar
  47. 47.
    Knesewitsch P, Gödel NH, Fritsch S et al. (1987) Beurteilung der Adriamycin-Kardiotoxizität mittels der Äquilibrium-Radionuklid-Ventrikulographie. II. Ergebnisse unter körperlicher Belastung. Nucl-Med 26: 212–219Google Scholar
  48. 48.
    Fowler NO (1973) Classification and diagnosis of myocardial diseases. In: Fowler NO (ed) Myocardial diseases. Grune & Stratton, New York London, p 25Google Scholar
  49. 49.
    Goodwin JF (1970) Congestive and hypertrophie cardiomyopathies. Lancet I: 731CrossRefGoogle Scholar
  50. 50.
    Tillmanns H, Zebe H, Mall G, Volk D, Kübler W (1981) Die alkoholische Herzschädigung. Internistische Welt 1: 40Google Scholar
  51. 51.
    Bolte HD (1983) Kardiale Schäden durch Alkoholüberkonsum. In: Olsen EGJ, Schrey A (Hrsg) International Society and Federation of Cardiology. Expertengespräche Venedig 1981. Klett, Stuttgart, S 350ff.Google Scholar
  52. 52.
    Bolte HD, Tebbe U (1979) Elektrophysiologische Untersuchungen bei Alkoholkardiomyopathie. In: Antoni, Bender, Gerlach (Hrsg) Herzrhythmusstörungen. Schattauer, Stuttgart New YorkGoogle Scholar
  53. 53.
    Demakis JG, Proskey A, Rahimtoola S, Jamil M, Sutton GC, Rosen KM, Gunnar RM, Tobin JR (1974) The natural course of alcoholic cardiomyopathy. Ann Intern Med 80: 293–297PubMedCrossRefGoogle Scholar
  54. 54.
    Wenger R (1964) Endokardfibrosen. Klinik, Therapie. Pathologie. Thieme, StuttgartGoogle Scholar
  55. 55.
    Schwaber JR, Lukas DS (1962) Hyperkinetic and cardiac failure in the carcinoid syndrome. Am J Med 32: 846 (1962)PubMedCrossRefGoogle Scholar
  56. 56.
    Klenk C (1984) Myokardfunktion bei Patienten mit So-matotropismus. Invasive and echokardiographische Un-tersuchungen mit pharmakologischen Funktionsprüfungen. Dissertation, Universität MünchenGoogle Scholar
  57. 57.
    Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE (1980) Sudden death in young athletes. Circulation 62: 218–229PubMedCrossRefGoogle Scholar
  58. 58.
    Kandolf R, Kirschner P, Ameis D et al. (1988) Enteroviral heart disease: Diagnosis by in situ hybridization. In: Schultheiß H-P (ed) New concepts in viral heart disease. Springer, Berlin Heidelberg New York Tokyo, S 337–348CrossRefGoogle Scholar
  59. 59.
    Böttcher D, Holper H, Meindl S et al. (1986) Muster der regionalen Wandbewegungsstörung bei primärer dilatativer Kardiomyopathie. Z Kardiol 75: 37–43PubMedGoogle Scholar
  60. 60.
    Follansbee WP (1987) Radionuclide imaging in primary and secondary disorders of the myocardium. In: Gerson MC (ed) Cardiac nuclear medicine. McGraw-Hill, New York/NY, pp 399–424Google Scholar
  61. 61.
    Das SK, Callen JP, Dodson VN, Cassidy JT (1971) Immunoglobulin binding in cardiomyopathic hearts. Circulation 44: 612PubMedCrossRefGoogle Scholar
  62. 62.
    Waterson AP (1978) Virological investigations in congestive cardiomyopathy. Postgrad Med J 54: 501CrossRefGoogle Scholar
  63. 63.
    Waagstein F, Hjalmarson A, Varnauskas E, Wallentin J (1975) Effect of chronic betaadrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37: 1022PubMedCrossRefGoogle Scholar
  64. 64.
    Brock R (1957) Functional obstruction of the left ventricle. Guy’s Hosp Rep 106: 221–238Google Scholar
  65. 65.
    Kochsiek K, Larbig D, Harmjanz D (1971) Die hypertrophische obstruktive Kardiomyopathie. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  66. 66.
    Büll U, Strauer BE (1981) Assessment of left ventricular muscle mass with 201-Thallium myocardial imaging. In: Strauer BE (ed) The heart in hypertension. Springer, Berlin Heidelberg New York, pp 345–356CrossRefGoogle Scholar
  67. 67.
    Narahara KA, Thompson CJ, Maublant JC et al. (1987) Thallium-201 SPECT estimates of left ventricular mass in patients with and without ischemic heart disease. Am Heart J 114: 84–90PubMedCrossRefGoogle Scholar
  68. 68.
    Perloff JK (1988) Neurological disorders and heart disease. In: Braunwald ED (ed) Heart disease. Saunders, London, pp 1782–1799Google Scholar
  69. 69.
    Schwartzkopff B, Frenzel H, Losse B, Borggrefe M, Toyka KV, Hammerstein W, Seitz R, Deckert M, Breithardt G (1986) Heart involvement in progressive external ophthalmoplegia (Kearns-Sayre-syndrome): Electrophysiologic, hemodynamic and morphologic findings. Z Kardiol 75: 161PubMedGoogle Scholar
  70. 70.
    Steere AC (1989) Lyme-Disease. N Engl J Med 321: 586–596PubMedCrossRefGoogle Scholar
  71. 71.
    Fahrer H, Sauvaen MJ, Linden S van der (1988) Praevalenz der Lyme-Borreliose in einer Schweizerischen Risi-kopopulation. Schweiz Med Wochenschr 118: 65–69PubMedGoogle Scholar
  72. 72.
    Roelli H, Gehrn W, Reutter FW (1989) Atrioventrikuläre Blockierung bei Lyme-Karditis. Schweiz Med Wochenschr 119: 81–83PubMedGoogle Scholar
  73. 73.
    Herxheimer H, Meyer-Büschenfelde KH, Pribilla W (eds) (1978) Die Auswahl antiinfektiöser Arzneimittel. Arzneimittelbrief 12: 93Google Scholar
  74. 74.
    Schölmerich P (1960) Erkrankungen des Endokard. In: Schwiegk H (Hrsg) Handbuch der inneren Medizin, Bd IX/II. Springer, Berlin Göttingen Heidelberg, S 543Google Scholar
  75. 75.
    Schölmerich P (1970) Bakterielle Endokarditis. In: Gross R, Jahn D, Schölmerich P (Hrsg) Lehrbuch der Inneren Medizin. Schattauer, Stuttgart, S 285Google Scholar
  76. 76.
    Maisch B et al. (1983) Immune complexes, serum factors, and cytotoxicity in endocarditis. Am Heart J 106: 338–344PubMedCrossRefGoogle Scholar
  77. 77.
    Pankey R (1979) The prevention and treatment of bacterial endocarditis. Am Heart J 98: 102PubMedCrossRefGoogle Scholar
  78. 78.
    Parrillo LE, Borer JS, Henry WL, Wolff SM, Fauci AS (1979) The cardiovascular manifestations of the hypereosinophilic syndrome. Am J Med 67: 572PubMedCrossRefGoogle Scholar
  79. 79.
    Maisch B (1987) Immunologische Parameter in der Diagnostik und Verlaufsbeobachtung der Endokarditis. In: Maisch B (Hrsg) Infektiöse Endokarditis. Perimed, Erlangen, S 1067–1077Google Scholar
  80. 80.
    Bolte HD (1984) Klinik der Endokarditis. In: Miehlke K (Hrsg) Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 90. Springer, Berlin Heidelberg New York, S117ff.Google Scholar
  81. 81.
    Rothlin ME (1984) Endokarditis nach Klappenersatz. In: Miehlke K (Hrsg) Verhandlungen der Deutschen Gesellschaft für innere Medizin, vol 90. Springer, Berlin Heidelberg New York, S 148 ff.Google Scholar
  82. 82.
    Roitt J (1977) Immunologie. Steinkopf, DarmstadtGoogle Scholar
  83. 83.
    Remmele W (1962) Die Erkrankungen des Wandendokards unter besonderer Berücksichtigung ihrer pathologischen Anatomie. Klin Wochenschr 40: 379–391PubMedCrossRefGoogle Scholar
  84. 84.
    Buccino RA, Spann JF, Poole PE, Braunwald E (1967) Influence of the thyroid state on the intrinsic contractile properties and the energy stores of the myocardium. J Clin Invest 46: 1669PubMedCrossRefGoogle Scholar
  85. 85.
    Feldman T, Borow KM, Same DM, Neumann A, Lang RM (1986) Myocardial mechanics in hyperthyroidism: Importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 7: 972CrossRefGoogle Scholar
  86. 86.
    Bolte HD, Grothey K (1977) Cardiomyopathies related to immunological processes. In: Riecker G, Weber A, Goodwin J (eds) Myocardial failure. Springer, Berlin Heidelberg New York, p 266CrossRefGoogle Scholar
  87. 87.
    Dressler W (1959) The post-myocardial-infarction syndrome. Arch Intern Med 103: 28CrossRefGoogle Scholar
  88. 88.
    Knesewitsch P et al. (1987) J Nucl Med 26: 212–219Google Scholar
  89. 89.
    Schultheiss, H-P (1989) Zur Frage der immunsuppressiven Therapie bei Myokarditis und dilatativer Kardiomyopathie. Z. Kardiol 78: 349–359PubMedGoogle Scholar
  90. 90.
    Arbeitsgem. Endokarditis d. Paul Ehrlich-Gesellschaft (1988) Empfehlungen zur Prophylaxe der bakteriellen Endokarditis — Z. antimikrobielle antineoplastische Chemotherapie 6: 9–12Google Scholar
  91. 91.
    Bolte HO (1985) Immunological Defects Precursors of Myocarditis and Dilated Cardiomyopathy? J Mol Cell Cardiol 17 (Suppl. 2) 69–71PubMedCrossRefGoogle Scholar
  92. 92.
    Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophic Cardiomyopathy. Interrelations of Clinical Manifestations, Pathophysiology, and Therapy NEJM. 316: 844–852PubMedCrossRefGoogle Scholar
  93. 93.
    Coplan NL, Bruno MS (1989) Acquired immunodeficiency syndrome and heart disease: The present and the future. Am Heart J: 1175-1177Google Scholar
  94. 94.
    Bowles NE, Richardson PJ, Olsen EGJ, Archard LC (1986) Delection of Coxsackie-B-Virus-specific RNA Sequences in Myocardial Biopsy Samples from Patients with Myocarditis and Dilated Cardiomyopathy. Lancet No. 8490, 1120CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Gerhard Riecker
    • 1
  1. 1.Medizinische Klinik IKlinikum Großhadern, Universität MünchenMünchenDeutschland

Personalised recommendations